#AMCP2026 is officially wrapped. The biggest takeaway for non-attendees: this meeting is where evidence, policy, and real-world decision-making collide — and where people build the relationships that help them act on it. #AMCP2026
Today in managed care: Reuters reported that effective July 1, Cigna will no longer cover GLP-1 drugs in its employee health plan. A Cigna spokesperson said, “As availability has increased and new options have emerged, we’ve made the decision to end our plan’s coverage for GLP-1s for weight loss.”
https://t.co/zqztf3O5KU
AMCP is working to solve the metabolic health crisis by advancing guidance, education, and collaboration to support aligned coverage, equitable access, and improved outcomes.
Learn more at: https://t.co/rz0IkEf9zZ
#metabolic-health #GLP-1 #ManagedCare
Today in managed care: USA Today reports, “A study of more than 111,000 women...found that those who took popular GLP-1 drugs prescribed for obesity or diabetes had a more than 30% lower risk of breast cancer.” Investigators came to this conclusion after examining “the health records of more than 111,000 women ages 45 to 80 who were overweight and had breast imaging done at Penn Medicine facilities.”
https://t.co/1uYUSGcdBX
AMCP is bringing managed care pharmacy professionals together to address rising health costs and inequities through coordinated, upstream approaches to metabolic disease prevention and treatment.
Catch up on this initiative here, https://t.co/UiZooOozDn
#WeAreMCPs#WeAreAMCP #ImprovePatientCare #GLP1s
Advance Through Education
Expand expertise and confidence with AMCP! Stay ahead with member exclusive top-tier webinars, conferences, resources, interest groups, and training.
Sign up today: https://t.co/OR8bQpD24G
#WeAreMCPs#WeAreAMCP#AMCPEducation
Today in managed care: Reuters reports, “Global health organization CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of shots against Ebola Bundibugyo.”
https://t.co/4RHEcMCjSi
Earn CE Credits through this podcast!
In the newest episode of Unscripted Amy Lugo,PharmD, BCPS, BC-ADM, FAPhA, FAMCP, and host Steve Kheloussi PharmD, MBA, FAMCP, break down orexin-2 receptor agonists, patient stories that'll change how you write PA criteria, and why this isn't just another "new drug".
This activity is supported by an independent medical education grant from Takeda Pharmaceuticals U.S.A., Inc. AMCP offers CPE for this podcast through June 30, 2027.
→ Listen + claim CE (free through 6/30/27) here: https://t.co/RobRw0wPZi
#Narcolepsy #freeCE #ManagedCare
Today in managed care: Reuters reported that President Trump signed an executive order “to acknowledge a recent scientific assessment by the Department of Health and Human Services on childhood vaccines as a guide for the federal government, the White House said on Friday.”
https://t.co/X5X8O2E89V
Today in managed care: The New York Times reports a study found that the experimental drug bepirovirsen “has essentially cured 1 in 5 patients with chronic hepatitis B infections.”
https://t.co/x0AUpxtzSg
Today in managed care: Fierce Healthcare reports, “GoodRx announced Wednesday the launch of GoodRx Companion, a subscription program that offers access to virtual healthcare services and prescription medications at discounted prices.” With the $14.99 monthly “subscription, users can access free and low-cost generic medications, online care visits and additional healthcare services.
https://t.co/ShCWuM1DK8
AMCP is building standards and best practices for AI in managed care pharmacy
Ensuring patient-centered, ethically sound, and strategically aligned implementation across pharmacy practice and policy.
Learn more at https://t.co/dcDMTwyiH4
#ManagedCare#Ai#WeAreMCPs
Today in managed care: The Hill reports the FDA’s advisory committee on vaccines "this week will consider whether to change the COVID-19 vaccine to target the XFG subvariant for the upcoming 2026-2027 respiratory viral season."
https://t.co/SYRvnq3S8n
Advancing Managed Care Pharmacy Together
Real people. Real experience. Real results. For managed care pharmacy professionals, AMCP is the only community to advance their knowledge, skills, and mindset.
Learn more: https://t.co/3VlwaiK8kE
#WeAreMCPs #WeAreAMCP#RealMCPVoices #AMCPMembersBenefit
Join a community focused on education, advocacy, and insights that support your growth and help you advance your career in managed care pharmacy.
Join today: https://t.co/PaEYRu7gHI
#WeAreMCPs#WeAreAMCP
Did you participate in Legislative Days?
Your Voice Matters! Be sure to share it. Upload videos and photos to Entribe to share your advocacy for managed care pharmacy, patient access, and affordability on AMCP platforms.
https://t.co/t8r9e4sn55
#WeAreAMCP#ManagedCare #Pharmacy
AMCP is working with health care stakeholders to overcome challenges and enhance the integration of Real-World Evidence (RWE) into health care decision-making.
Learn more at https://t.co/TUhp3iNWtv
#RWE#ManagedCare
Take action now! patients deserve modern care.
Right now, lawmakers are considering the Access to Prescription Digital Therapeutics Act (H.R. 3288 / S. 1702), which would help close an access gap for Medicare and Medicaid beneficiaries by creating a new benefit category and expanding Medicare coverage to include prescription digital therapeutics.
Send a message to your lawmaker now: https://t.co/te8OxAmMRa
#WeAreAMCP #ManagedCare #Pharmacy #PDTAccessAct
Advocacy Alert! Thank you to @WaysandMeansGOP @WaysandMeansDems members for advancing the Main Street Pharmacy Access Act.
This is a key step in improving access to pharmacist-provided care for Medicare patients — in states that already authorize pharmacists to perform these services.
We appreciate AMCP members whose advocacy helped move this forward!
Read press release: https://t.co/u8XzRs4733
#WeAreAMCP #Patientaccess #ECAPS #ManagedCare #Pharmacy #LegislativeDays #AMCPAdvocacy
Take action now! Patients can’t lose care.
Right now, lawmakers are considering the Ensuring Community Access to Pharmacist Services (ECAPS) Act (H.R. 3164/ S.2426), which would help ensure patients can continue to rely on pharmacists for essential services like testing and treatment for COVID‑19, RSV, and the flu. Your voice can strengthen readiness for future public health threats.
Send a message to your lawmaker now: https://t.co/UCiuuMs6iw
#WeAreAMCP #ManagedCare #Pharmacy #ECAPSAct